Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Hemovent

Hemovent
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series B LATEST DEAL TYPE
$5.2M LATEST DEAL AMOUNT
10 INVESTORS
Description

Developer of portable artificial lungs designed to support or replace heart and lung function in the event of a cardiac or respiratory failure. The company's artificial lungs provide respiratory support to patients whose lungs are so damaged that they cannot perform their function, or as a temporary life support system and take over the heart function in case of acute heart failure, enabling physicians with enough time to address the underlying problems that caused the failure.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • Rottstr. 33
  • 52068 Aachen
  • Germany

+49 0241 0000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Hemovent’s full profile, request a free trial.

Hemovent Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series B) 14-Feb-2019 $5.2M 000.00 000.00 Completed Generating Revenue
4. Accelerator/Incubator 00.000 Completed Generating Revenue
3. Early Stage VC (Series A) 25-Jul-2017 00.000 00.000 000.00 Completed Generating Revenue
2. Grant 24-Apr-2017 $810K $6M Completed Generating Revenue
1. Early Stage VC (Series A) 10-Feb-2016 $6M $6M 000.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Hemovent Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ALung Venture Capital-Backed Pittsburgh, PA 00 00000 0000000000 0 00000
00 000000 Venture Capital-Backed Milpitas, CA 00 00000 0000000000 0 00000
0000000 Corporation Danvers, MA 0000 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Hemovent Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Government of Germany Government 000 0000 000000 0
First Capital Partner Venture Capital Minority 000 0000 000000 0
KfW Group Investment Bank Minority 000 0000 000000 0
MIG AG Venture Capital Minority 000 0000 000000 0
NRW.Bank Investment Bank Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Hemovent Executive Team (2)

Name Title Board
Seat
Contact
Info
Christof Lenz Co-Founder & Chief Executive Officer
Oliver Marseille Ph.D Co-Founder & Chief Technology Officer